- $6.77bn
- $7.84bn
- $5.44bn
- 88
- 62
- 45
- 71
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,505 | 4,588 | 5,458 | 5,435 | 5,441 |
Cost of Revenue | |||||
Gross Profit | 1,996 | 2,249 | 2,630 | 2,492 | 2,582 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,467 | 4,214 | 4,728 | 4,759 | 4,880 |
Operating Profit | 37.1 | 375 | 730 | 676 | 562 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -160 | 178 | 471 | 504 | 465 |
Provision for Income Taxes | |||||
Net Income After Taxes | -218 | 112 | 891 | 368 | 196 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -219 | 124 | 903 | 394 | 214 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -219 | 124 | 903 | 394 | 214 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.561 | 0.377 | 2.6 | 1.16 | 0.658 |